Garret A. FitzGerald
Garret A. FitzGerald
Dirección de correo verificada de
Citado por
Citado por
Collaborative overview of randomised trials of antiplatelet therapy Prevention of death, myocardial infarction, and stroke by prolonged antiplatelet therapy in various …
A Trialists' Collaboration
Bmj 308 (6921), 81, 1994
Prostaglandins and inflammation
E Ricciotti, GA FitzGerald
Arteriosclerosis, thrombosis, and vascular biology 31 (5), 986-1000, 2011
The coxibs, selective inhibitors of cyclooxygenase-2
GA FitzGerald, C Patrono
New England Journal of Medicine 345 (6), 433-442, 2001
Cyclooxygenase inhibitors and the antiplatelet effects of aspirin
F Catella-Lawson, MP Reilly, SC Kapoor, AJ Cucchiara, S DeMarco, ...
New England Journal of Medicine 345 (25), 1809-1817, 2001
Oxidative stress and cardiovascular injury: Part I: basic mechanisms and in vivo monitoring of ROS
KK Griendling, GA FitzGerald
Circulation 108 (16), 1912-1916, 2003
Platelet-active drugs: the relationships among dose, effectiveness, and side effects: the Seventh ACCP Conference on Antithrombotic and Thrombolytic Therapy
C Patrono, B Coller, GA FitzGerald, J Hirsh, G Roth
Chest 126 (3), 234S-264S, 2004
Systemic biosynthesis of prostacyclin by cyclooxygenase (COX)-2: the human pharmacology of a selective inhibitor of COX-2
BF McAdam, F Catella-Lawson, IA Mardini, S Kapoor, JA Lawson, ...
Proceedings of the National Academy of Sciences 96 (1), 272-277, 1999
Platelet activation in unstable coronary disease
DJ Fitzgerald, L Roy, F Catella, GA FitzGerald
New England Journal of Medicine 315 (16), 983-989, 1986
Biological basis for the cardiovascular consequences of COX-2 inhibition: therapeutic challenges and opportunities
T Grosser, S Fries, GA FitzGerald
The Journal of clinical investigation 116 (1), 4-15, 2006
Coxibs and cardiovascular disease
GA FitzGerald
New England Journal of Medicine 351 (17), 1709-1711, 2004
Prostaglandin E2 regulates vertebrate haematopoietic stem cell homeostasis
TE North, W Goessling, CR Walkley, C Lengerke, KR Kopani, AM Lord, ...
Nature 447 (7147), 1007-1011, 2007
BMAL1 and CLOCK, two essential components of the circadian clock, are involved in glucose homeostasis
RD Rudic, P McNamara, AM Curtis, RC Boston, S Panda, JB Hogenesch, ...
PLoS Biol 2 (11), e377, 2004
Role of prostacyclin in the cardiovascular response to thromboxane A2
Y Cheng, SC Austin, B Rocca, BH Koller, TM Coffman, T Grosser, ...
Science 296 (5567), 539-541, 2002
A functional genomics strategy reveals Rora as a component of the mammalian circadian clock
TK Sato, S Panda, LJ Miraglia, TM Reyes, RD Rudic, P McNamara, ...
Neuron 43 (4), 527-537, 2004
Biomarkers of oxidative stress study II: are oxidation products of lipids, proteins, and DNA markers of CCl4 poisoning?
MB Kadiiska, BC Gladen, DD Baird, D Germolec, LB Graham, CE Parker, ...
Free Radical Biology and Medicine 38 (6), 698-710, 2005
Effects of specific inhibition of cyclooxygenase-2 on sodium balance, hemodynamics, and vasoactive eicosanoids
F Catella-Lawson, B McAdam, BW Morrison, S Kapoor, D Kujubu, L Antes, ...
Journal of Pharmacology and Experimental Therapeutics 289 (2), 735-741, 1999
Human platelet/erythroleukemia cell prostaglandin G/H synthase: cDNA cloning, expression, and gene chromosomal assignment
CD Funk, LB Funk, ME Kennedy, AS Pong, GA Fitzgerald
The FASEB Journal 5 (9), 2304-2312, 1991
Modulation of oxidant stress in vivo in chronic cigarette smokers
M Reilly, N Delanty, JA Lawson, GA FitzGerald
Circulation 94 (1), 19-25, 1996
Endogenous biosynthesis of prostacyclin and thromboxane and platelet function during chronic administration of aspirin in man.
GA FitzGerald, JA Oates, J Hawiger, RL Maas, LJ Roberts, JA Lawson, ...
The Journal of clinical investigation 71 (3), 676-688, 1983
Clinical Implications of Prostaglandin and Thromboxane A2 Formation
JA Oates, GA FitzGerald, RA Branch, EK Jackson, HR Knapp, LJ Roberts
New England Journal of Medicine 319 (11), 689-698, 1988
El sistema no puede realizar la operación en estos momentos. Inténtalo de nuevo más tarde.
Artículos 1–20